BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9458786)

  • 1. Peripheral mediators involved in gastric hyperemia to vagal activation by central TRH analog in rats.
    Király A; Sütö G; Guth PH; Taché Y
    Am J Physiol; 1998 Jan; 274(1):G170-7. PubMed ID: 9458786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide in gastric hyperemia induced by central vagal stimulation.
    Tanaka T; Guth P; Taché Y
    Am J Physiol; 1993 Feb; 264(2 Pt 1):G280-4. PubMed ID: 8447409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms mediating gastric hyperemic and acid responses to central TRH analog at a cytoprotective dose.
    Király A; Sütó G; Guth PH; Taché Y
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G31-8. PubMed ID: 9252506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central vagal activation by TRH induces gastric hyperemia: role of CGRP in capsaicin-sensitive afferents in rats.
    Kiràly A; Sütö G; Livingston EH; Guth PH; St Pierre S; Taché Y
    Am J Physiol; 1994 Dec; 267(6 Pt 1):G1041-9. PubMed ID: 7810651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric hyperemic response during vagally mediated acid secretion by TRH analog in rats.
    Kato S; Hirata T; Kitamura M; Takeuchi K
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1351-7. PubMed ID: 9316846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsaicin-sensitive vagal afferents contribute to gastric acid and vascular responses to intracisternal TRH analog.
    Raybould HE; Holzer P; Reddy SN; Yang H; Taché Y
    Peptides; 1990; 11(4):789-95. PubMed ID: 2122423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central vagal activation by an analogue of TRH stimulates gastric nitric oxide release in rats.
    Saperas E; Mourelle M; Santos J; Moncada S; Malagelada JR
    Am J Physiol; 1995 Jun; 268(6 Pt 1):G895-9. PubMed ID: 7541945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketotifen prevents gastric hyperemia induced by intracisternal thyrotropin-releasing hormone at a low dose.
    Király A; Süto G; Guth PH; Taché Y
    Eur J Pharmacol; 1997 Sep; 334(2-3):241-7. PubMed ID: 9369354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of [4Cl-D-Phe6,Leu17]VIP on VIP- and central TRH-induced gastric hyperemia.
    Király A; Sütó G; Guth P; Taché Y
    Peptides; 1997; 18(9):1321-5. PubMed ID: 9392832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central thyrotropin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats.
    Yoneda M; Taché Y
    Gastroenterology; 1992 May; 102(5):1568-74. PubMed ID: 1568566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways.
    Yang H; Kawakubo K; Taché Y
    Am J Physiol; 1999 Sep; 277(3):G555-62. PubMed ID: 10484380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide in the gastric cytoprotection induced by central vagal stimulation.
    Király A; Sütö G; Taché Y
    Eur J Pharmacol; 1993 Aug; 240(2-3):299-301. PubMed ID: 7694860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagus-mediated activation of mucosal mast cells in the stomach: effect of ketotifen on gastric mucosal lesion formation and acid secretion induced by a high dose of intracisternal TRH analogue.
    Király A; Süto G; Tam B; Hermann V; Mózsik G
    J Physiol Paris; 2000; 94(2):131-4. PubMed ID: 10791694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagal mechanisms underlying gastric protection induced by chemical activation of raphe pallidus in rats.
    Kaneko H; Kaunitz J; Taché Y
    Am J Physiol; 1998 Nov; 275(5):G1056-62. PubMed ID: 9815036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: central and peripheral mechanisms.
    Taché Y; Yoneda M; Kato K; Király A; Sütö G; Kaneko H
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S29-35. PubMed ID: 7881015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracisternal TRH and RX 77368 potently activate gastric vagal efferent discharge in rats.
    O-Lee TJ; Wei JY; Taché Y
    Peptides; 1997; 18(2):213-9. PubMed ID: 9149293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracisternal thyrotropin-releasing hormone on hepatic blood flow in rats.
    Tamori K; Yoneda M; Nakamura K; Makino I
    Am J Physiol; 1998 Feb; 274(2):G277-82. PubMed ID: 9486180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prostaglandins and calcitonin gene-related peptide in central vagal cholinergic-dependent protection against gastric injury in urethane-anesthetized rats.
    Kato K; Yang H; Taché Y
    Digestion; 1996; 57(5):322-7. PubMed ID: 8886575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
    Yoneda M; Kurosawa M; Watanobe H; Terano A
    J Gastroenterol Hepatol; 2003 Feb; 18(2):177-84. PubMed ID: 12542603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-CT or DOI augments TRH analog-induced gastric acid secretion at the dorsal vagal complex.
    Varanasi S; Chi J; Stephens RL
    Am J Physiol; 1997 Nov; 273(5):R1607-11. PubMed ID: 9374800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.